Figure 5.

Patients receiving or qualified to receive public financial support for HAE treatment according to attack frequency. We found that all respondents of the high attack group (n = 19/19, 100%) and 22 out of 29 respondents (75.9%) in the low attack group were receiving public renumeration. Those in the no attack and asymptomatic groups were more likely to report that they do not receive public renumeration (n = 2/7, 28.6% and n = 4/7, 57.1%, respectively). Abbreviation: HAE, Hereditary angioedema.